<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1008142.ref036">
 <label>36</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Shi</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Hua</surname>
   <given-names>X</given-names>
  </name>, 
  <name>
   <surname>Kong</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Stein</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Hua</surname>
   <given-names>F</given-names>
  </name> (
  <year>2019</year>) 
  <article-title>Role of Toll-like receptor mediated signaling in traumatic brain injury</article-title>. 
  <source>Neuropharmacology</source>
  <volume>145</volume>: 
  <fpage>259</fpage>â€“
  <lpage>267</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.neuropharm.2018.07.022</pub-id>
  <?supplied-pmid 30075158?>
  <pub-id pub-id-type="pmid">30075158</pub-id>
 </mixed-citation>
</ref>
